RN7SL803P

Across TCGA pan-cancer cohorts, RN7SL803P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL803P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RN7SL803P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL803P is over-expressed in tumor, although a few such as KIRP and THCA show the opposite, repressed pattern.

KIRP, THCA, and PAAD are the cancer types where RN7SL803P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL803P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	II,III,IV	−0.154	.005	6	view →
THCA	All	All	−0.117	.005	5	view →
PAAD	Male	All	+0.370	.017	4	view →
STAD	All	II,III,IV	+0.312	.045	1	view →
LUSC	Male	II,III,IV	−0.133	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL803P–KIRP

Open the KIRP breakdown →